chr1-67182777-T-C
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_144701.3(IL23R):c.368-59T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.892 in 1,605,410 control chromosomes in the GnomAD database, including 640,409 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_144701.3 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IL23R | NM_144701.3 | c.368-59T>C | intron_variant | Intron 3 of 10 | ENST00000347310.10 | NP_653302.2 | ||
| IL23R | XM_011540790.4 | c.368-59T>C | intron_variant | Intron 3 of 10 | XP_011539092.1 | |||
| IL23R | XM_011540791.4 | c.368-59T>C | intron_variant | Intron 3 of 10 | XP_011539093.1 | |||
| IL23R | XM_047447227.1 | c.368-59T>C | intron_variant | Intron 3 of 10 | XP_047303183.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IL23R | ENST00000347310.10 | c.368-59T>C | intron_variant | Intron 3 of 10 | 1 | NM_144701.3 | ENSP00000321345.5 |
Frequencies
GnomAD3 genomes AF: 0.914 AC: 139042AN: 152154Hom.: 63727 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.890 AC: 1293627AN: 1453138Hom.: 576622 AF XY: 0.891 AC XY: 644151AN XY: 723232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.914 AC: 139160AN: 152272Hom.: 63787 Cov.: 32 AF XY: 0.913 AC XY: 67973AN XY: 74464 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
This variant is classified as Benign based on local population frequency. This variant was detected in 99% of patients studied by a panel of primary immunodeficiencies. Number of patients: 87. Only high quality variants are reported.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at